Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 947-787-5 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Skin irritation / corrosion
Administrative data
- Endpoint:
- skin irritation: in vivo
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Further information is included under 'Attached justification' in IUCLID section 13 and 'Cross-reference'.
Cross-reference
- Reason / purpose for cross-reference:
- read-across: supporting information
Reference
- Endpoint:
- skin irritation: in vivo
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- study well documented, meets generally accepted scientific principles, acceptable for assessment
- Justification for type of information:
- REPORTING FORMAT FOR THE ANALOGUE APPROACH
Further information is included under 'Attached justification' in IUCLID section 13 and 'Cross-reference'. - Reason / purpose for cross-reference:
- read-across source
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test:
Determine the skin irritation potential in the human 4-h patch test.
- Short description of test conditions: Patch tests with the test material are applied to human skin for up to 4 hours.
- Parameters analysed / observed: The presence of irritation is observed at 24, 48 and 72 hours after patch removal. - GLP compliance:
- not specified
- Species:
- other: Human
- Strain:
- not specified
- Type of coverage:
- not specified
- Preparation of test site:
- not specified
- Vehicle:
- not specified
- Controls:
- yes, concurrent positive control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.2 ml
- Concentration (if solution): Not specified - Duration of treatment / exposure:
- Test materials applied progressively for 15 minutes, 30 minutes, 1, 2, 3 and 4 hours. Each progressive application is at a new skin site.
- Observation period:
- Treatment sites assessed at 24, 48 and 72 hours after patch removal.
- Number of animals:
- 29
- Details on study design:
- TEST SITE
- Type of patch: 25 mm plain Hill Top Chamber containing a Webril pad
- Site of application: Skin of the upper outer arm
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Reversibility:
- not specified
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Remarks on result:
- other: Not reported.
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Remarks on result:
- other: Not reported.
- Irritant / corrosive response data:
- Of the 29 skin patches applied to humans, none produced positive irritant reactions.
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Palmitic acid was non-irritating in the human patch test.
- Executive summary:
The relative irritancy of palmitic acid was assessed in a human patch test. Plain 25 mm Hill Top Chamber patches, containing a Webril pad, with 0.2 ml palmitic acid, were applied to the skin of the upper outer arm of 29 human volunteers for up to 4 hours. The patches were removed after 4 hours, and the skin reaction at each site was observed 24, 48 and 72 hours after patch removal. Of the 29 humans assessed, 0 showed positive irritancy reactions when treated with palmitic acid patch tests. Therefore, palmitic acid was considered non-irritating.
Data source
Reference
- Reference Type:
- publication
- Title:
- Determination of skin irritation potential in the human 4-h patch test
- Author:
- Basketter DA, York M, McFadden JP, Robinson MK
- Year:
- 2 004
- Bibliographic source:
- Contact Dermatitis 51:1-4
Materials and methods
Test guideline
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Principle of test:
Determine the skin irritation potential in the human 4-h patch test.
- Short description of test conditions: Patch tests with the test material are applied to human skin for up to 4 hours.
- Parameters analysed / observed: The presence of irritation is observed at 24, 48 and 72 hours after patch removal. - GLP compliance:
- not specified
Test material
- Reference substance name:
- Palmitic acid
- EC Number:
- 200-312-9
- EC Name:
- Palmitic acid
- Cas Number:
- 57-10-3
- Molecular formula:
- C16H32O2
- IUPAC Name:
- palmitic acid
Constituent 1
Test animals
- Species:
- other: Human
- Strain:
- not specified
Test system
- Type of coverage:
- not specified
- Preparation of test site:
- not specified
- Vehicle:
- not specified
- Controls:
- yes, concurrent positive control
- Amount / concentration applied:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 0.2 ml
- Concentration (if solution): Not specified - Duration of treatment / exposure:
- Test materials applied progressively for 15 minutes, 30 minutes, 1, 2, 3 and 4 hours. Each progressive application is at a new skin site.
- Observation period:
- Treatment sites assessed at 24, 48 and 72 hours after patch removal.
- Number of animals:
- 29
- Details on study design:
- TEST SITE
- Type of patch: 25 mm plain Hill Top Chamber containing a Webril pad
- Site of application: Skin of the upper outer arm
Results and discussion
In vivo
Resultsopen allclose all
- Irritation parameter:
- overall irritation score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Score:
- 0
- Reversibility:
- not specified
- Remarks on result:
- no indication of irritation
- Irritation parameter:
- erythema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Remarks on result:
- other: Not reported.
- Irritation parameter:
- edema score
- Basis:
- mean
- Time point:
- 24/48/72 h
- Remarks on result:
- other: Not reported.
- Irritant / corrosive response data:
- Of the 29 skin patches applied to humans, none produced positive irritant reactions.
Applicant's summary and conclusion
- Interpretation of results:
- study cannot be used for classification
- Conclusions:
- Palmitic acid was non-irritating in the human patch test.
- Executive summary:
The relative irritancy of palmitic acid was assessed in a human patch test. Plain 25 mm Hill Top Chamber patches, containing a Webril pad, with 0.2 ml palmitic acid, were applied to the skin of the upper outer arm of 29 human volunteers for up to 4 hours. The patches were removed after 4 hours, and the skin reaction at each site was observed 24, 48 and 72 hours after patch removal. Of the 29 humans assessed, 0 showed positive irritancy reactions when treated with palmitic acid patch tests. Therefore, palmitic acid was considered non-irritating.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.